ATE374210T1 - Verfahren zur identifikation von modulatoren von hif-1-alpha - Google Patents

Verfahren zur identifikation von modulatoren von hif-1-alpha

Info

Publication number
ATE374210T1
ATE374210T1 AT99958594T AT99958594T ATE374210T1 AT E374210 T1 ATE374210 T1 AT E374210T1 AT 99958594 T AT99958594 T AT 99958594T AT 99958594 T AT99958594 T AT 99958594T AT E374210 T1 ATE374210 T1 AT E374210T1
Authority
AT
Austria
Prior art keywords
alpha
human hif
essentially
domain
hif
Prior art date
Application number
AT99958594T
Other languages
English (en)
Inventor
Anders Berkenstam
Lorenz Poellinger
Original Assignee
Angiogenetics Sweden Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Angiogenetics Sweden Ab filed Critical Angiogenetics Sweden Ab
Application granted granted Critical
Publication of ATE374210T1 publication Critical patent/ATE374210T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Radar Systems Or Details Thereof (AREA)
  • Amplifiers (AREA)
  • Semiconductor Lasers (AREA)
  • Testing, Inspecting, Measuring Of Stereoscopic Televisions And Televisions (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
AT99958594T 1998-11-13 1999-11-11 Verfahren zur identifikation von modulatoren von hif-1-alpha ATE374210T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE9803891A SE9803891D0 (sv) 1998-11-13 1998-11-13 Protein Variants

Publications (1)

Publication Number Publication Date
ATE374210T1 true ATE374210T1 (de) 2007-10-15

Family

ID=20413284

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99958594T ATE374210T1 (de) 1998-11-13 1999-11-11 Verfahren zur identifikation von modulatoren von hif-1-alpha

Country Status (15)

Country Link
EP (1) EP1141005B1 (de)
JP (1) JP2002530063A (de)
KR (1) KR100648761B1 (de)
CN (1) CN1330666C (de)
AT (1) ATE374210T1 (de)
AU (1) AU761594B2 (de)
BR (1) BR9915263A (de)
CA (1) CA2350830A1 (de)
DE (1) DE69937199D1 (de)
HK (1) HK1043372B (de)
NZ (1) NZ511450A (de)
SE (1) SE9803891D0 (de)
TR (1) TR200101345T2 (de)
WO (1) WO2000029437A1 (de)
ZA (1) ZA200103669B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9911047D0 (en) 1999-05-12 1999-07-14 Isis Innovation Assay method and means
ATE383877T1 (de) * 1999-06-04 2008-02-15 Dana Farber Cancer Inst Inc Identifikation von stoffen, die transkriptionelle antworten auf hypoxia modifizieren
WO2001092578A2 (en) * 2000-05-26 2001-12-06 Board Of Trustees Of The University Of Illinois Reagents and methods for identifying and modulating expression of genes regulated by retinoids
CA2418386A1 (en) * 2000-08-07 2002-02-14 Angiogenetics Sweden Ab Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein
US20030045830A1 (en) * 2001-04-17 2003-03-06 De Bizemont Therese Gene therapy with chimeric oligonucleotides delivered by a method comprising a step of iontophoresis
EP1842856A3 (de) * 2001-05-23 2007-12-12 Angiogene Inc. Hypoxieerzeugende Faktoren und ihre Verwendung zur Herbeiführung von Angiogenese und Verbesserung der Muskelfunktionen
WO2002094862A2 (en) 2001-05-23 2002-11-28 Angiogene Inc. Hypoxia inducible factors and uses thereof for inducing angiogenesis and improving muscular functions
WO2003064587A2 (en) * 2002-01-11 2003-08-07 Angio Genetics Sweden Ab Hif-1 alpha proteins mutated in the c-terminal transactivation domain
CN100366747C (zh) * 2005-03-08 2008-02-06 上海第二医科大学附属仁济医院 低氧诱导因子小干扰rna质粒
CN100418574C (zh) * 2005-10-26 2008-09-17 王成球 一类封闭人类HIF-1α基因和调控网络中下游相关基因的染色质肽
CN102127161B (zh) * 2010-12-16 2013-03-27 何明忠 抗肿瘤多肽及其用途
CN106366173A (zh) * 2015-07-24 2017-02-01 北京京爱康科技有限公司 一种通过结合低氧反应元件控制缺氧反应基因表达的染色质肽

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882914A (en) * 1995-06-06 1999-03-16 The Johns Hopkins University School Of Medicine Nucleic acids encoding the hypoxia inducible factor-1

Also Published As

Publication number Publication date
SE9803891D0 (sv) 1998-11-13
KR100648761B1 (ko) 2006-11-23
TR200101345T2 (tr) 2001-10-22
AU761594B2 (en) 2003-06-05
JP2002530063A (ja) 2002-09-17
CA2350830A1 (en) 2000-05-25
EP1141005B1 (de) 2007-09-26
ZA200103669B (en) 2002-05-07
HK1043372A1 (en) 2002-09-13
WO2000029437A1 (en) 2000-05-25
EP1141005A1 (de) 2001-10-10
AU1593100A (en) 2000-06-05
DE69937199D1 (de) 2007-11-08
CN1330663A (zh) 2002-01-09
CN1330666C (zh) 2007-08-08
NZ511450A (en) 2003-08-29
KR20010080411A (ko) 2001-08-22
HK1043372B (zh) 2008-05-09
BR9915263A (pt) 2001-10-30

Similar Documents

Publication Publication Date Title
ATE352617T1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
DE69937199D1 (de) Verfahren zur identifikation von modulatoren von hif-1-alpha
DE69411268D1 (de) Verfahren zur schnellen quantifizierung von microorganismenwachstum
IL130036A0 (en) Survivin a protein that inhibits cellular apoptosis and its modulation
DE60023936D1 (de) Methoden zur verwendung von randomisierten zinkfingerprotein-bibliotheken zur identifizierung von genfunktionen
EP1137941A4 (de) Proteingerüste für antikörper-nachahmer und andere bindende proteine
DE69614198D1 (de) EPR4 Postprozessor mit reduzierter Komplexität zur Detektion von abgetasteten Daten
DE69332621T2 (de) Verfahren zum Erfassen von Software und Informationssystem zur Anwendung dieses Verfahrens
DE69431161T2 (de) Verfahren zur verbesserung von benzin
BR9912545A (pt) ácidos nucleicos codificando um receptorcopulado a proteìna g envolvido em transduçãosensorial
DE59706588D1 (de) Telekommunikationsendgerät zur Projektion von visuell erfassbarer Information
ATE382148T1 (de) Antikörper für apoptosemarker und anwendungsverfahren
DE69022425T2 (de) Verfahren zur Bestimmung der funktionellen Wirkung von freiem Protein S oder Protein C in einer Plasmaprobe.
DE69430777T2 (de) Verfahren zur Dateiverwaltung von austauschbaren Datenträgern
ATE241703T1 (de) Verfahren zur identifizierung unbekannter allele
DE69720738D1 (de) Zusammensetzung und verfahren zur verhinderung von proteinablagerung auf kontaktlinsen
DE59404520D1 (de) Verfahren zur Hydroformylierung von Butadien-1.3
DE69712878T2 (de) Phosphatasemodulator
DE69629653D1 (de) Methode zur bestimmung der ursache von defekten auf stahloberflächen
DE69319752D1 (de) Verfahren zur identifizierung von analyten
AR007279A1 (es) Composicion para la tincion y tonalizacion de cabellos
DE69407720T2 (de) Verfahren zur Hydroxycarbonylierung von Butadien
DE58901435D1 (de) Verfahren zur herstellung von dipeptiden mit n-terminalen nichtproteinogenen aminosaeuren.
DE69628797D1 (de) Verfahren zur verhinderung von harzablagerungen
DE59004279D1 (de) Verfahren zur C-terminalen Modifizierung von Proteinen.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties